How do palliative medicine physicians assess and manage depression

Abstract

Depression is a significant symptom for approximately 25% of palliative care patients, but is frequently unrecognized and untreated. This study was carried out to determine how senior doctors working in palliative medicine in the UK assessed and managed depression in their patients. A questionnaire was sent to all palliative care units with a designated consultant or medical director. Questions were asked about assessment and management of depression (pharmacological and nonpharmacological); difficulties encountered, qualifications and current post. The response rate was 63%; two-thirds (90) of respondents were consultants and a further 21 medical directors. The majority (73%) routinely assessed for depression with 27% using the Hospital Anxiety and Depression (HAD) Scale and 10% asking the patient 'are you depressed'? The most frequently prescribed medication was SSRI (80%). Less than 6% prescribed psychostimulants. Respondents reported difficulties with the assessment and management of depression which mainly focused on distinguishing symptoms of depression from sadness and whether it was appropriate to treat patients when life expectancy was short. Difficulties were identified in accessing psychiatric input by 47%. Depression is identified as being a difficult symptom to manage by many senior palliative care physicians in the UK and suggestions are made as to how some of theses issues can be addressed.

Keywords

assessment depression management palliative care psychiatry

Get full access to this article

View all access options for this article.

References

Block S . Assessing and managing depression in the terminally ill patient. Ann Intern Med 2000; 32: 209-218.

Hotopf M , Chidgey J , Addington-Hall J , Lan Ly K . Depression in advanced disease: a systematic review. Part 1: prevalence and case ” nding. Palliat Med 2002; 16: 81-97.

Maguire P . Improving the detection of psychiatric problems in cancer patients. Soc Sci Med 1985; 20: 819-823.

Brugha T . Depression in the terminally ill. Br J Hosp Med 1993; 50: 175-181.

Razavi D , Stiefel F . Common psychiatric disorders in cancer patients: adjustment disorders and depressive disorders. Review article. Support Cancer Care 1994; 2: 223-232.

Tucker J . Modi” cation of attitudes to in‘ uence survival from breast cancer. Lancet 1999; 354: 1320-1320.

Casey P . Depression in the dying-disorder or distress. Prog Palliat Care 1994; 2: 1-3.

Buckberg J . Penman D , Holland J . Depression in hospitalised cancer patients. Psychosom Med 1984; 46: 199-211.

Endicott J . Measurement of depression in patients with cancer. Cancer 1984; 53: 2243-2248.

10.

Ibbotson T , Maguire P , Selby T , Priestman T , Wallace L . Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1993; 30A: 1, 37-40.

11.

Silverstone P . Is anhedonia a good measure of depression? Acta Psychiatry Scand 1991; 83: 249-250.

12.

Le Fevre P , Devereux J , Smith S , Lawrie SM , Cornbleet M . Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med 1999; 12: 399-407.

13.

Lloyd-Williams M , Friedman T , Rudd N . An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage 2001; 22: 990-996.

14.

Lloyd-Williams M , Friedman T , Rudd N . Criterion validation of the Edinburgh Postnatal Depression Scale as a screening tool for depression in patients with advanced metastatic cancer. J Pain Symptom Manage 2000; 20: 259-265.

15.

Chochinov H , Wilson K , Enns M , Lander S . Are you depressed? Screening for depression in the terminally ill. Am J Psychiatry 1997; 154: 674-676.

16.

Mahoney J , Drinka T , Abler R , Gunter-Hunt G , Matthews C , Gravenstein S , Carnes M . Screening for depression: single question versus GDS. J Am Geriatr Soc 1994; 42: 1006-1008.

17.

Lloyd-Williams M , Dennis M , Taylor F , Baker I . A prospective study to determine whether it is appropriate to ask palliative care patients ‘are you depressed’. BMJ 2003; 327: 372-373.

18.

Lloyd-Williams M , Friedman T , Rudd N . A survey of psychosocial service provision within hospices. Palliat Med 1999; 13: 431-432.

19.

Fallow”eld L , Radcliffe D , Jenkins V . Saul J . Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001; 84: 1011-1015.

20.

Maguire P . The use of antidepressants in patients with advanced cancer. Support Care Cancer 2000; 8: 265-267.

21.

Lloyd-Williams M , Friedman T , Rudd N . A survey of antidepressant prescribing in the terminally ill. Palliat Med 1999; 13: 243-248.

22.

Hotopf M . Hardy R , Lewis G . Discontinuation rates of SSRI's and tricyclics: a meta analysis and investigation of heterogeneity. Br J Psychiatry 1997; 170: 120-127.

23.

Gill D , Hatcher S . A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness. J Psychosomatic Res 1999; 47: 131-143.

24.

Martin A , Jackson K . Depression in palliative care patients. Hospice J 2000; 7: 71-78.

25.

Homsi J , Nelson K , Sarhill N , et al. A phase II study of methylphenidate for depression in advanced cancer. Am J Hospice Palliat Care 2001; 18: 403-407.

26.

Chilvers C , Dewey M , Fielding K , et al. Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ 2001; 322: 772-775.

27.

Lloyd-Williams M , Payne S . Nurse specialist assessment and management of palliative care patients who are depressed-a study of perceptions and attitudes. J Palliat Care 2002; 18: 270-275.

28.

Lloyd-Williams M , Payne S . A qualitative study of palliative care nurses' perceptions on depression. Palliat Med 2003; 17: 334-339.